Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to email@example.com so that we can defer those challenges. Your health and safety are paramount to us.
Posted 26 January 2016 | By Zachary Brennan
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) added Australia’s TFS Manufacturing to a list of medical device manufacturers that have not met device quality system requirements.
TFS says it manufactures a tissue fixation system that “repairs organ prolapse by tensioning the ligaments and bringing laterally displaced connective tissue structures, such as ligaments and fascia, together. It combines soft tissue anchors with a polypropylene tape, fixed internally alongside the ligament and precisely tensioned using minimally invasive surgery.”
Although FDA does not list the company’s specific quality system deficiencies, TFS, which has yet to respond to a request for comment from Focus, joins more than 130 foreign companies on the list from more than 25 different countries.
“Foreign inspections of device manufacturers are being performed and detention without physical examination (DWPE) may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices (GMP's),” FDA says. “DWPE may also be appropriate when FDA receives information concerning inspections conducted by foreign or other government authorities under a Memorandum of Understanding or other agreement that FDA concludes reveal conditions or practices warranting detention of either particular products or all products manufactured by a firm.”
The import alert on TFS and all other firms the list will remain in effect until FDA is satisfied that the appearance of a violation has been removed, either by re-inspection or submission of appropriate documentation.
So far this year, FDA has added three companies to the list, including China’s Xiantao Tongda Non-woven Products Co. and Taiwan’s E-Care Technology.
Import Alert List
Tags: import alert, device quality, quality system compliance